IRIS
MEDAGLINI, DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.292
EU - Europa 8.574
AS - Asia 4.268
SA - Sud America 793
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 9
AN - Antartide 1
Totale 23.021
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.146
RU - Federazione Russa 2.003
CN - Cina 1.539
GB - Regno Unito 1.474
SG - Singapore 1.404
IE - Irlanda 1.196
IT - Italia 1.165
BR - Brasile 677
SE - Svezia 652
DE - Germania 543
UA - Ucraina 520
HK - Hong Kong 365
FI - Finlandia 354
FR - Francia 339
VN - Vietnam 293
KR - Corea 286
IN - India 113
CA - Canada 83
ES - Italia 61
PL - Polonia 48
NL - Olanda 46
BD - Bangladesh 41
AR - Argentina 39
MX - Messico 36
JP - Giappone 34
BE - Belgio 33
AT - Austria 32
TR - Turchia 29
ZA - Sudafrica 26
UZ - Uzbekistan 24
EC - Ecuador 21
IQ - Iraq 21
CZ - Repubblica Ceca 19
LT - Lituania 17
CI - Costa d'Avorio 15
PK - Pakistan 15
ID - Indonesia 14
IR - Iran 13
CH - Svizzera 12
CL - Cile 10
CO - Colombia 10
IL - Israele 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
EG - Egitto 9
EU - Europa 9
GR - Grecia 9
SA - Arabia Saudita 9
BO - Bolivia 7
DK - Danimarca 7
MA - Marocco 7
PE - Perù 7
AU - Australia 6
DO - Repubblica Dominicana 6
KE - Kenya 6
MY - Malesia 6
PT - Portogallo 6
BG - Bulgaria 5
PY - Paraguay 5
UY - Uruguay 5
AZ - Azerbaigian 4
JO - Giordania 4
KG - Kirghizistan 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
JM - Giamaica 3
LK - Sri Lanka 3
MT - Malta 3
NZ - Nuova Zelanda 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
NP - Nepal 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GD - Grenada 1
GS - Georgia del Sud e Isole Sandwich Australi 1
Totale 23.004
Salva come PNG Salva come JPEG
Città #
Dallas 1.394
Southend 1.208
Dublin 1.193
Fairfield 889
Singapore 794
Ashburn 733
Chandler 679
Moscow 541
Santa Clara 503
Jacksonville 419
Woodbridge 400
Beijing 393
Siena 368
Hong Kong 358
Houston 329
Seattle 329
Wilmington 313
Cambridge 297
Hefei 285
Seoul 279
Ann Arbor 246
Princeton 199
Munich 176
Los Angeles 163
Helsinki 161
Nanjing 135
New York 133
Dong Ket 121
Milan 108
Florence 76
Lappeenranta 73
San Mateo 73
Rome 72
The Dalles 72
Boardman 66
San Diego 66
Shanghai 60
Lancaster 59
Buffalo 56
São Paulo 55
Shenyang 50
Ho Chi Minh City 48
Menlo Park 48
Hanoi 45
Nanchang 42
Turku 40
London 39
Redondo Beach 39
Nuremberg 38
Bengaluru 37
Council Bluffs 36
Tokyo 33
Chicago 32
Brussels 31
Columbus 31
Dearborn 30
Tianjin 28
Toronto 28
Denver 27
Málaga 27
Montreal 26
San Francisco 26
Warsaw 26
Düsseldorf 25
Kunming 25
Phoenix 25
Washington 24
Hebei 23
Jiaxing 23
Belo Horizonte 21
Fremont 21
Frankfurt am Main 20
Guangzhou 20
Tashkent 20
Brooklyn 19
Poplar 18
Rio de Janeiro 18
Amsterdam 17
Chennai 17
Norwalk 17
Atlanta 16
Changsha 16
Abidjan 15
Lauterbourg 15
Messina 15
Orem 15
Redwood City 15
Jinan 14
Portsmouth 14
Zhengzhou 14
Dhaka 13
Stockholm 13
Vienna 13
Brno 12
Lastra a Signa 12
Boston 11
Curitiba 11
Hangzhou 11
Johannesburg 11
Mexico City 11
Totale 15.301
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 321
13C-NMR determination of simultaneous xylose and glucose fermentation by a newly isolated strain (G11) of Klebsiella planticola 319
Vaginal immunization to elicit primary T-cell activation and dissemination 305
A stochastic model for CD4+ T cell proliferation and dissemination network in primary immune response 296
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 290
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 277
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 276
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 272
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 260
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 257
Correlates of vaccine-induced protective immunity against Ebola virus disease 253
Adoptive transfer of transgenic T cells to study mucosal adjuvants 250
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 249
Ebola vaccine R&D: Filling the knowledge gaps 244
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 243
Role of the microbiota in the modulation of vaccine immune responses 243
Identification of a branching process model for adaptive immune response 241
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 240
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae 237
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells 236
Big science for vaccine development 236
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine 235
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 231
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 221
Assessment of mucosal immunity to HIV-1 220
Vaccination in the elderly: The challenge of immune changes with aging 218
Modulation of Primary Immune Response by Different Vaccine Adjuvants 213
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 212
Biotechnological approaches to fight pathogens at mucosal sites 199
The European research effort for HIV/AIDS, malaria and tuberculosis 195
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii 191
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii 189
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 189
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 189
Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface 187
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 187
ADITEC: joining forces for next-generation vaccines 187
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 185
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 185
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 184
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 184
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 183
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 179
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 177
Vaccine adjuvants: A priority for vaccine research 177
Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii 174
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 174
Recombinant Gram-positive bacteria as vehicles of vaccine antigens 173
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 172
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 169
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 168
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 167
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 166
O:2-CRM(197) Conjugates against Salmonella Paratyphi A 166
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 164
Gram-positive commensal bacteria for mucosal vaccine delivery. 161
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 161
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 160
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice 159
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 159
Innate immunity against HIV: a priority target for HIV prevention research 157
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 156
Primary T-cell response to mucosal vaccination 156
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 155
Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines 155
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 154
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 154
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 152
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 152
The European effort towards the development of mucosal vaccines for poverty-related diseases 152
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 151
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 151
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 150
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 150
Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against Salmonella typhimurium and Salmonella Enteritidis 150
Surface display of recombinant proteins on Bacillus subtilis spores 149
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 149
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 148
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 148
In vivo mucosal delivery of bioactive human interleukin 1 recepor antagonist produced by Streptococcus gordonii 148
Impact of interproximal composite restorations on periodontal tissue health: Clinical and cytokine profiles from a pre-post quasi-experimental study 147
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 146
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 146
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts 145
NMR Investigation of the Simultaneous Fermentation of Xylose and Glucose by a Selected Strain of Klebsiella Planticola (G11) 145
Vaginal immunization with recombinant gram-positive bacteria 143
Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. 142
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens 142
La diagnosi eziologica della polmonite comunitaria: possibile ruolo della Real-Time PCR in una coorte di pazienti adulti e pediatrici 142
Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii 142
Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis 142
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 141
Editorial: Advanced Immunization Technologies for Next Generation Vaccines 139
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 138
Expression of foreign proteins on gram-positive commensal bacteria for mucosal vaccine delivery. 138
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization 137
Expression of measles virus antigens in Streptococcus gordonii 134
Immune Memory After Respiratory Infection With Streptococcus pneumoniae Is Revealed by in vitro Stimulation of Murine Splenocytes With Inactivated Pneumococcal Whole Cells: Evidence of Early Recall Responses by Transcriptomic Analysis 133
Recombinant Streptococcus gordonii as a mucosal vaccine vector 133
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 131
Totale 18.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.401 0 0 0 0 0 192 83 253 236 253 175 209
2021/20221.596 117 226 98 159 64 27 85 53 84 143 184 356
2022/20232.363 147 238 319 306 213 466 61 206 182 49 119 57
2023/20242.030 73 67 160 118 79 518 668 65 43 87 35 117
2024/20254.399 129 179 429 249 536 278 204 265 435 180 424 1.091
2025/20266.415 780 1.462 1.040 1.218 1.842 73 0 0 0 0 0 0
Totale 23.312